Influenza and Other Respiratory Viruses

Papers
(The H4-Index of Influenza and Other Respiratory Viruses is 25. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-04-01 to 2024-04-01.)
ArticleCitations
Medical masks vs N95 respirators for preventing COVID‐19 in healthcare workers: A systematic review and meta‐analysis of randomized trials326
COVID‐19 transmission through asymptomatic carriers is a challenge to containment206
COVID‐19: Face masks and human‐to‐human transmission134
COVID‐19 vaccine hesitancy and attitudes in Qatar: A national cross‐sectional survey of a migrant‐majority population111
Increased risk of rhinovirus infection in children during the coronavirus disease‐19 pandemic97
Respiratory syncytial virus disease burden in adults aged 60 years and older in high‐income countries: A systematic literature review and meta‐analysis75
Influenza and COVID‐19: What does co‐existence mean?74
SARS‐CoV‐2 environmental contamination associated with persistently infected COVID‐19 patients60
COVID‐19 severity from Omicron and Delta SARS‐CoV‐2 variants57
Effectiveness of the MF59‐adjuvanted trivalent or quadrivalent seasonal influenza vaccine among adults 65 years of age or older, a systematic review and meta‐analysis53
Epidemiological, clinical, and virological characteristics of 465 hospitalized cases of coronavirus disease 2019 (COVID‐19) from Zhejiang province in China51
Differential COVID‐19 case positivity in New York City neighborhoods: Socioeconomic factors and mobility50
Early epidemiological investigations: World Health Organization UNITY protocols provide a standardized and timely international investigation framework during the COVID‐19 pandemic48
Which influenza viruses will emerge following the SARS‐CoV‐2 pandemic?48
Evidence for pre‐symptomatic transmission of coronavirus disease 2019 (COVID‐19) in China47
Defining the seasonality of respiratory syncytial virus around the world: National and subnational surveillance data from 12 countries43
Admission respiratory status predicts mortality in COVID‐1938
Sixty‐eight consecutive patients assessed for COVID‐19 infection: Experience from a UK Regional infectious diseases Unit36
The economic burden of influenza among adults aged 18 to 64: A systematic literature review36
International changes in respiratory syncytial virus (RSV) epidemiology during the COVID‐19 pandemic: Association with school closures35
The immunogenicity and safety of respiratory syncytial virus vaccines in development: A systematic review34
Population anxiety and positive behaviour change during the COVID‐19 epidemic: Cross‐sectional surveys in Singapore, China and Italy33
The impact of the 2009 influenza pandemic on the seasonality of human respiratory syncytial virus: A systematic analysis31
Associations between persistent symptoms after mild COVID‐19 and long‐term health status, quality of life, and psychological distress30
Impact of coronavirus disease 2019 on respiratory surveillance and explanation of high detection rate of human rhinovirus during the pandemic in the Republic of Korea25
0.028013944625854